UCB to buy Schwarz as drug fusion fever continues
104635
Belgian drugmaker UCB UCBBt.BR has   agreed to buy Germany's Schwarz Pharma SRZG.DE for around 4.4   billion euros ($5.6 billion) in stock and cash in the third   major drug sector transaction in Germany in five days.
182817
Drug giant Johnson & Johnson agrees to buy Guidant Corp, a key player in the heart technology market, for $25.4bn.
349840
Pfizer Inc. PFE.N is close to an  agreement to buy Angiosyn Inc., a biotech start-up working on a  drug to ward off blindness, in a deal potentially valued at  $527 million, the Wall Street Journal reported on Thursday,  citing people familiar with the situation.
725625
German chemicals and pharmaceuticals giant Bayer says it is still open to further acquisitions even though it was still in the process of integrating Berlin-based drug maker Schering which it recently acquired for close to 17 billion euros (22 billion dollars).
506286
BOSTON (CBS.MW) - Pharmaceutical powerhouse Pfizer is buying a 5 percent stake in biotechnology researcher Medarex under their newly signed collaboration deal, according to Medarex Chief Executive Donald Drakeman.
429782
Battery maker Rayovac Corp. ROV.N is  close to a deal to acquire privately held United Industries  Corp., a maker of lawn and garden products, for about $476  million in cash and stock in a bid to diversify its product  mix, sources close to the situation said on Monday.
91019
Johnson &amp; Johnson, the pharmaceutical and health care giant, has announced an agreement to buy Guidant, one of the largest US makers of devices to treat heart and circulatory illnesses, for $25.4 billion.
176562
By Karen Attwood  The Dutch healthcare and chemicals group Akzo Nobel ditched plans to float its biopharmaceutical division in favour of a sale yesterday, triggering speculation it would next make a move on the chemicals group Imperial Chemical Industries.
115138
Pharmaceutical giant AstraZeneca PLC said Monday it bought a 20 percent stake in biology company Cambridge Antibody Technology as the two companies announced a US$175 million five-year research and development alliance on inflammatory disorders, including
73388
Cytec Industries Inc., a US maker of materials for the aerospace and car industries, agreed to buy the chemicals business of UCB SA, Belgium&#39;s largest drugmaker, for 1.5 billion euros ($1.
749001
Analysts welcomed news reports that UBS  AG UBSN.VX was set to buy Charles Schwab's SCH.N  institutional research and trading unit for $265 million on  Monday, saying it would fortify the bank's market activities.
205867
German drug maker Schering, recently acquired by pharmaceuticals and chemicals giant Bayer, has said that it was teaming up with British drug giant AstraZeneca to develop a new treatment against breast cancer.
10428
Advanced Medical Optics Inc.  has offered to buy larger eye-care company Bausch & Lomb Inc.  for $4.23 billion, topping a rival offer of $3.67 billion from private equity firm Warburg Pincus , the two companies said on Thursday.
10567
Cytec Industries Inc. is buying the chemicals division of Belgian drugs company UCB in a 1.5 billion euro ($1.85 billion) cash and stock deal, the US specialty chemical firm said on Friday.
611507
SAN FRANCISCO (CBS.MW) -- Cytec Industries Inc.&#39;s acquisition of the surface specialties business from UCB will produce a quick and significant revenue boost, Credit Suisse First Boston said Friday.
738544
The cancer diagnostic equipment maker is expected to announce that it will acquire Spring Bioscience, a developer of antibodies, for $28.9 million in cash.
338909
Germany&#39;s Bayer has agreed to sell its blood products business to US investment firms Cerberus and Ampersand Ventures for about $590 million as it continues to narrow the focus of its health-care business.